IRIS
RENDA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.840
EU - Europa 3.354
AS - Asia 2.250
SA - Sud America 151
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 1
Totale 9.618
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.812
SG - Singapore 878
CN - Cina 718
IE - Irlanda 687
UA - Ucraina 627
IT - Italia 527
TR - Turchia 475
SE - Svezia 471
GB - Regno Unito 261
DE - Germania 229
FR - Francia 180
BR - Brasile 140
FI - Finlandia 139
RU - Federazione Russa 117
IN - India 60
HK - Hong Kong 33
AT - Austria 24
BE - Belgio 22
IR - Iran 22
PL - Polonia 21
CA - Canada 20
VN - Vietnam 18
NL - Olanda 12
EU - Europa 10
CZ - Repubblica Ceca 9
EG - Egitto 6
IL - Israele 6
IQ - Iraq 6
MX - Messico 6
JP - Giappone 5
RO - Romania 5
BD - Bangladesh 4
EC - Ecuador 4
LT - Lituania 4
DK - Danimarca 3
ES - Italia 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
KZ - Kazakistan 2
PH - Filippine 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
CH - Svizzera 1
CO - Colombia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GR - Grecia 1
ID - Indonesia 1
JM - Giamaica 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 9.618
Salva come PNG Salva come JPEG
Città #
Jacksonville 756
Dublin 668
Chandler 649
Singapore 574
Princeton 337
Izmir 224
Nanjing 201
Southend 196
Ashburn 153
Altamura 118
Dearborn 117
Cambridge 116
Santa Clara 115
Wilmington 112
Beijing 111
The Dalles 103
Nanchang 87
Ann Arbor 79
Chieti 67
Los Angeles 51
Pescara 40
Boardman 39
Hebei 39
Shenyang 39
Woodbridge 38
Kunming 35
Hong Kong 32
New York 30
Tianjin 26
Washington 25
Augusta 24
Jiaxing 23
Munich 23
San Mateo 23
Brussels 22
Changsha 22
Grevenbroich 22
Norwalk 22
Leawood 20
Helsinki 18
Ardabil 17
Camerino 17
Teramo 17
Dong Ket 15
Falls Church 15
Kraków 15
Hangzhou 14
Guangzhou 12
Düsseldorf 11
Houston 11
São Paulo 11
Hefei 10
Rome 10
Toronto 10
Lappeenranta 9
Milan 9
Moscow 9
Nuremberg 9
Vienna 9
Bologna 8
Brno 8
Lanzhou 8
Shanghai 8
Brooklyn 7
Frankfurt am Main 7
Seattle 7
Taizhou 7
Amsterdam 6
Atlanta 6
Bari 6
Chicago 6
Council Bluffs 6
Jinan 6
Monmouth Junction 6
Rio de Janeiro 6
Belo Horizonte 5
Cairo 5
Messina 5
Mumbai 5
Roslyn Heights 5
Xi'an 5
Auburn Hills 4
Beersheba 4
Brasília 4
Brindisi 4
Fort Worth 4
Fuzhou 4
L'aquila 4
Ningbo 4
Ottawa 4
Paris 4
Redwood City 4
Romola 4
San Francisco 4
Tappahannock 4
Tokyo 4
Turku 4
Zhengzhou 4
Ascoli Piceno 3
Bangalore 3
Totale 5.838
Salva come PNG Salva come JPEG
Nome #
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 131
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 117
Effects of endurance, resistance and neuro-muscular electrical stimulation trainings to the anthropometric and functional mobility domains in elderly 115
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 113
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 113
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 110
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 103
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 102
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 96
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 96
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 90
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 90
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 90
Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? 89
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial 87
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 86
Genetic determinants of blood pressure responses to caffeine drinking 86
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 85
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease 85
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 84
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 83
Facilitated PCI: Rationale, current evidence, open questions and future directions 82
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 82
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 82
INCREASED THROMBOXANE PRODUCTION BY MONOCYTE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 81
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 81
Coffee: Health Effects 80
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 80
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 80
The left atrial appendage: from embryology to prevention of thromboembolism 78
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial 78
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 77
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves 76
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 75
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF 75
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 75
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes 74
Cardiovascular and psychological reactivity after caffeine consumption 73
Cardiovascular effects of caffeine during cognitive tasks 73
Dose- Dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 72
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN MAN. 72
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 72
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W 71
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina 71
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 71
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 71
An early decline of collateral circulation parallels myocardial ischaemia during percutaneous coronary intervention: a drawback of recanalization of chronic coronary occlusions? 70
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy 70
The legacy of ISCHEMIA 70
Echocardiographic screening for the anomalous aortic origin of coronary arteries 70
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 69
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 69
AF: current and forthcoming antithrombotic therapies 69
New anticoagulants for atrial fibrillation 68
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 68
Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 68
Blood pressure modifications after caffeine intake during cognitive tasks 67
MECHANISMS OF ISOPROSTANE BIOSYNTHESIS IN HUMANS 66
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects 66
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry 66
Enhanced thromboxane biosynthesis in patients with colorectal and lung cancer 66
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 66
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 66
Ambulatory blood pressure and risk of new-onset atrial fibrillation in treated hypertensive patients 66
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 64
Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring 64
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 63
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 63
Surgical bleeding after preoperative unfractionated heparin and low molecular weight heparin at coronary bypass surgery 62
Antithrombotic management 62
Risk of Atrial Fibrillation in Masked and White Coat Uncontrolled Hypertension 62
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 62
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 62
Prognostic Significance of Chest Imaging by LUS and CT in COVID-19 Inpatients: The ECOVID Multicenter Study 62
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES 61
Measurements of thromboxane production and their clinical significance in coronary heart disease 61
A comparison between unfractioned heparin and a low molecular weight heparin in cardiac surgery 61
Nutrigenetics of blood pressure responses to coffee drinking 60
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 60
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban 59
Parmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 59
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 59
DIFFERENTIAL INHIBITION OF HUMAN PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-1 AND -2 BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 58
Autonomic nervous system dysfunction in obese children 58
The AVERROES Trial – Clinical Implications 58
Late coronary thrombosis after drug-eluting stent: stent vs patient-driven prescription of aspirin-clopidogrel combination 58
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 58
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES. 57
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension 57
Aspirin Resistance 57
Antithrombotic prophylaxis in the elderly with atrial fibrillation 57
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 57
Effect of fibrinogen concentration on the antiplatelet effect of tirofiban 57
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN HUMAN BEINGS 56
Circadianicity of hemostatic function and coronary vasomotion 56
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 56
P6223Relationship between platelet indices and future cardiovascular events: results from a population-based cohort study 56
Ruolo del fibrinogeno e della conta piastrinica sull’inibizione dell’aggregazione piastrinica da parte dei farmaci anti-glicoproteina IIbIIIa 55
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 55
A comparison between unfractionated heparin and a low molecular weight heparin in cardiac surgery 54
Totale 7.299
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.373
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020167 0 0 0 0 0 0 0 0 0 0 161 6
2020/2021947 130 4 144 25 112 170 22 22 36 102 142 38
2021/2022691 12 5 5 126 82 8 17 62 64 18 71 221
2022/20232.004 182 282 117 193 181 391 139 137 268 23 51 40
2023/2024961 75 17 57 11 51 299 221 46 11 29 30 114
2024/20252.086 168 442 348 83 61 96 88 124 314 192 170 0
Totale 10.250